Massachusetts General Hospital is launching Boston’s second hand transplant program, hoping eventually to pioneer a new way of replacing patients’ limbs without subjecting them to a lifetime of dangerous antirejection drugs - an advance that could turn a rare operation into a routine one. Curtis Cetrulo, MGH Instructor in Surgery, Peter Slavin, MGH CEO, and Michael Zinner, head of the department of Surgery at Brigham and Women’s Hospital, are quoted.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure